News & Insights
Sort By
Insights 12 Results
Insights
|May 21, 2021
Once considered an unorthodox path to going public, direct listings are gaining traction as an alternative to the traditional IPO. On Wednesday, the Securities and Exchange Commission (SEC) approved a rule change, with immediate effect, that will permit companies to raise capital in a direct listing on the Nasdaq Global Select Market.
Insights
|August 12, 2020
FAQs on SPACs (Special Purpose Acquisition Companies)
Over the last several months, we have seen a dramatic interest among successful venture-backed companies in pursuing an exit with SPACs (Special Purpose Acquisition Companies). An exit via a SPAC entity may be the right option for companies looking to raise capital and obtain access to the public markets in lieu of a traditional IPO.
Insights
|May 4, 2020
Gunderson Dettmer capital markets partner Jeff Vetter recently spoke on a panel with Skadden attorneys about public companies and financing options in the currently unpredictable capital markets.
Events 2 Results
Events
|June 27, 2024
Webinar: IPO Readiness: Setting the Stage for a Successful IPO
Watch the webinar, "IPO Readiness: Setting the Stage for a Successful IPO" hosted by Jeff Vetter, Andy Thorpe and Alexa Belonick
Events
|February 15, 2024
Webinar: Everything You Need To Know About Dual-Class Stock
Gunderson Dettmer Partner Jeff Vetter and advisor Brett Pletcher hosted the Post-IPO Summit webinar, "Everything You Need To Know About Dual-Class Stock."
Client News 41 Results
Client News
|June 4, 2026
Gunderson Dettmer Advises Aeva on $115 Million Follow-On Offering
Aeva Technologies, Inc., a leader in next-generation sensing and perception systems, announces its $115.0 million public offering.
Client News
|May 18, 2026
Gunderson Dettmer Represents Hims & Hers in Upsized $402.5 Million Convertible Senior Notes Offering
Gunderson Dettmer advised Hims & Hers (NYSE: HIMS) in its offering of $402.5 million aggregate principal amount of 0.00% convertible senior notes due 2032.
Client News
|February 25, 2026
Gunderson Dettmer Advises Vir Biotechnology on Underwritten Public Offering
Vir Biotechnology announces its underwritten public offering of 20,294,117 shares of common stock at $8.50 per share, including the exercise in full of the underwriters’ option to purchase additional shares.
Firm News 10 Results
Firm News
|June 4, 2026
Chambers USA 2026 Guide Recognizes Multiple Gunderson Dettmer Practice Areas and Partners
The 2026 Chambers and Partners USA Guide recognized Gunderson Dettmer as a leading law firm in ten departments, including Corporate/M&A, Employee Benefits & Executive Compensation, Private Equity, Startups & Emerging Companies, Technology, and Venture Capital.
Firm News
|August 21, 2025
Best Lawyers Recognizes 38 Gunderson Dettmer Attorneys in the 2026 Best Lawyers in America Guide
Best Lawyers recognizes 38 Gunderson Dettmer attorneys across both the 2026 editions of The Best Lawyers in America list and Best Lawyers: Ones to Watch in America, continuing the legacy of celebrating exceptional legal professionals who have distinguished themselves through insight, expertise, and commitment to excellence
Firm News
|June 9, 2025
Gunderson Dettmer Practice Areas and Partners Recognized by Chambers USA 2025 Guide
Chambers and Partners recognized Gunderson Dettmer as a leading law firm in eight departments in its 2025 Chambers USA Guide
